ConductScience.org, home

Paper41865210

Immediate Second Look After Cytoreduction for Colorectal or Ovarian Carcinomatosis: An Invisible Gorilla Effect?

Dumont F and 6 others. Ann Surg Oncol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Immediate Second Look After Cytoreduction for Colorectal or Ovarian Carcinomatosis: An Invisible Gorilla Effect? Papers, record 41865210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41865210

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immediate Second Look After Cytoreduction for Colorectal or Ovarian Carcinomatosis: An Invisible Gorilla Effect?
PubMed
Journal
Ann Surg Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-07-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dumont FFrédérichttps://orcid.org/0000-0002-2840-8206
2Cosse LLola
3Thibaudeau EEmilie
4Bourgin CCharlotte
5Heymann MFMarie-Françoise
6Pothier JJohanna
7Vignaud TTimothée

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Peritoneal NeoplasmsMajor topic
Cytoreduction Surgical ProceduresMajor topic
Colorectal NeoplasmsMajor topic
Second-Look SurgeryMajor topic
Neoplasm, ResidualMajor topic
Humans
Female
Middle Aged
Prospective Studies
Aged
Prognosis
Follow-Up Studies

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
226163953Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.Dis Colon Rectum2015https://conductscience.org/library/papers/26163953PubMed
319103728Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.J Clin Oncol2009https://conductscience.org/library/papers/19103728PubMed
433476595
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol2021https://conductscience.org/library/papers/33476595PubMed
529342393Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.N Engl J Med2018https://conductscience.org/library/papers/29342393PubMed
632027455
Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
Colorectal Dis2020https://conductscience.org/library/papers/32027455PubMed
720737573
Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.
Cancer2010https://conductscience.org/library/papers/20737573PubMed
831592510Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.BJS Open2019https://conductscience.org/library/papers/31592510PubMed
926442921Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.Ann Surg Oncol2016https://conductscience.org/library/papers/26442921PubMed
1033028623Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).Int J Gynecol Cancer2020https://conductscience.org/library/papers/33028623PubMed
1123572282Object-based attention without awareness.Psychol Sci2013https://conductscience.org/library/papers/23572282PubMed
1210694957Gorillas in our midst: sustained inattentional blindness for dynamic events.Perception1999https://conductscience.org/library/papers/10694957PubMed
1330746598Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol2019https://conductscience.org/library/papers/30746598PubMed
1432717180
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Lancet Oncol2020https://conductscience.org/library/papers/32717180PubMed
1538577794Development of a Deep Learning System for Intraoperative Identification of Cancer Metastases.Ann Surg2024https://conductscience.org/library/papers/38577794PubMed
1630421052Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques.Ann Surg Oncol2019https://conductscience.org/library/papers/30421052PubMed
1733618910Individual learning curve of cytoreductive surgery for peritoneal metastasis from colorectal cancer: A process with an impact on survival.Eur J Surg Oncol2021https://conductscience.org/library/papers/33618910PubMed
1829420428
Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
Dis Colon Rectum2018https://conductscience.org/library/papers/29420428PubMed
1939043835Sustained attention can be measured using a brief computerized attention task.Sci Rep2024https://conductscience.org/library/papers/39043835PubMed
2030014885Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?Eur J Cancer2018https://conductscience.org/library/papers/30014885PubMed

See all 26 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41865210

GET https://conductscience.org/api/papers/v1/41865210/references?page=2